kynurenine has been researched along with Dyskinesia, Medication-Induced in 3 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Parkinson's disease is a common progressive neurodegenerative disorder presenting with characteristic motor symptoms." | 2.53 | Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System. ( Fülöp, F; Majláth, Z; Toldi, J; Vécsei, L, 2016) |
| "L-3,4-Dihydroxyphenylalanine (L-DOPA) is the most effective drug in the symptomatic treatment of Parkinson's disease, but chronic use is associated with L-DOPA-induced dyskinesia in more than half the patients after 10 years of treatment." | 1.46 | Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia. ( Andersen, AD; Binzer, M; Blaabjerg, M; Faergeman, NJ; Gramsbergen, JB; Havelund, JF; Heegaard, NHH; Stenager, E, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Havelund, JF | 1 |
| Andersen, AD | 1 |
| Binzer, M | 1 |
| Blaabjerg, M | 1 |
| Heegaard, NHH | 1 |
| Stenager, E | 1 |
| Faergeman, NJ | 1 |
| Gramsbergen, JB | 1 |
| Majláth, Z | 1 |
| Toldi, J | 1 |
| Fülöp, F | 1 |
| Vécsei, L | 1 |
| Grégoire, L | 1 |
| Rassoulpour, A | 1 |
| Guidetti, P | 1 |
| Samadi, P | 1 |
| Bédard, PJ | 1 |
| Izzo, E | 1 |
| Schwarcz, R | 1 |
| Di Paolo, T | 1 |
1 review available for kynurenine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System.
Topics: Animals; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Kynurenine; Levodo | 2016 |
2 other studies available for kynurenine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia.
Topics: Adult; Aged; Antiparkinson Agents; Biomarkers; Denmark; Dyskinesia, Drug-Induced; Female; Humans; Ky | 2017 |
Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Drug Interactions; Dyskines | 2008 |